# Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)

> **NCT03015272** · PHASE2,PHASE3 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Autism

## Interventions

- **BEHAVIORAL:** Auditory-Motor Mapping Training
- **BEHAVIORAL:** Speech-Repetition Therapy

## Key facts

- **NCT ID:** NCT03015272
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2019-09
- **Final completion:** 2019-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03015272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03015272, "Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03015272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*